CVRx Logo_R_RGB_black.png
CVRx® Announces First Clinical Procedure with a New Ultrasound-Guided Implant Approach, the Latest Advancement in Barostim™ for the Treatment of Heart Failure Symptoms
June 10, 2021 11:19 ET | CVRx, Inc.
MINNEAPOLIS, June 10, 2021 (GLOBE NEWSWIRE) -- CVRx®, developer of the world’s first FDA-approved neuromodulation device to treat the symptoms of heart failure (HF), announced the completion of the...
Caregiver Action Net
Caregiver Action Network Announces New Resource for Families of Loved Ones with Heart Failure
June 08, 2021 13:46 ET | Caregiver Action Network
Washington, DC, June 08, 2021 (GLOBE NEWSWIRE) -- Hearing that a loved one has been diagnosed with heart failure brings fear, stress, and a whole lot of questions. Caregiver Action Network has...
AFFiRiS: Positive ph
AFFiRiS: Positive phase 1 results with immunotherapies targeting PCSK9 to treat hypercholesterolemia published by the European Journal of Clinical Pharmacology
May 27, 2021 05:00 ET | AFFiRiS AG
Repeated immunization with AFFITOPE® peptide active immunotherapy candidates AT04A and AT06A is safe, well-tolerated and induces a strong and long-lasting PCSK9-specific immune responseAT04A treatment...
Philips Azurion PCI procedure
Philips announces European availability of innovations to advance personalized and efficient cardiac care at EuroPCR 2021
May 18, 2021 04:00 ET | Royal Philips
May 18, 2021 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the European availability of new innovations in its unique...
In-clinic screening with Eko DUO and Eko AI
Eko’s AI Analysis Algorithm Validated as a Clinical Tool for Detecting Heart Murmurs
May 10, 2021 08:00 ET | Eko
OAKLAND, Calif., May 10, 2021 (GLOBE NEWSWIRE) -- Eko, a cardiopulmonary digital health company, today announced the peer-reviewed publication of a clinical study that found that the Eko artificial...
54741_Image_jpeg.jpg
Newly Published Study Demonstrates Clinical Utility of Daxor’s Blood Volume (BVA-100®) Diagnostic in the Assessment of Postural Tachycardia Syndrome (POTS)
April 29, 2021 08:31 ET | Daxor Corporation
NEW YORK, April 29, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, today announces new data demonstrating the clinical utility...
researchdrivelogo.jpg
Global Critical Care Devices Market to rise at a CAGR of 3.2%, surpassing $41.5 billion by 2027, Irrespective of the COVID-19 Turmoil - Exclusive Report [Pages-150] by Research Dive
April 27, 2021 09:15 ET | Research Dive
New York, USA, April 27, 2021 (GLOBE NEWSWIRE) -- A latest report on the global critical care devices market by Research Dive unfolds the impact of COVID-19 pandemic on the current and future growth...
Healthy Extracts Inc. (OTCQB: HYEX) Announces the Addition of Dr. Joel Kahn, Renowned Integrative Cardiologist, to Its Medical Board
April 20, 2021 08:30 ET | Healthy Extracts Inc.
LAS VEGAS, April 20, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Healthy Extracts Inc. (OTCQB: HYEX) (the “Company”), a leading developer and manufacturer of science-forward, clinically proven,...
ASE Announces New Editor-in-Chief of CASE, the Premier Cardiovascular Imaging Case Reports Journal
April 14, 2021 07:00 ET | American Society of Echocardiography
Durham, NC, April 14, 2021 (GLOBE NEWSWIRE) -- The American Society of Echocardiography (ASE) is proud to announce that Vincent L. Sorrell, MD, FACC, FASE, FSCCT, FSCMR, has accepted the position of...
Healthtech Solutions, Inc. (HLTT), Parent Company of Cutting-Edge Medical Technology Companies, Files Reg A With SEC
March 17, 2021 08:30 ET | Healthtech Solutions, Inc.
March 8, 2021, filing to raise up to $75 million.  Maximum of 1,500,000 shares of Series B preferred stock offered at price of $50 per share.Healthtech Solutions, Inc. is organized to pursue...